CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy

Am J Hum Genet. 2001 Jan;68(1):225-31. doi: 10.1086/316946. Epub 2000 Dec 5.

Abstract

Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is an uncommon, idiopathic partial epilepsy characterized by clusters of motor seizures occurring in sleep. We describe a mutation of the beta2 subunit of the nicotinic acetylcholine receptor, effecting a V287M substitution within the M2 domain. The mutation, in an evolutionary conserved region of CHRNB2, is associated with ADNFLE in a Scottish family. Functional receptors with the V287M mutation are highly expressed in Xenopus oocytes and characterized by an approximately 10-fold increase in acetylcholine sensitivity. CHRNB2 is a new gene for idiopathic epilepsy, the second acetylcholine receptor subunit implicated in ADNFLE.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Amino Acid Sequence
  • Amino Acid Substitution / genetics
  • Animals
  • Base Sequence
  • Child
  • Conserved Sequence
  • Electric Conductivity
  • Epilepsy, Frontal Lobe / genetics*
  • Epilepsy, Frontal Lobe / metabolism
  • Epilepsy, Frontal Lobe / physiopathology
  • Female
  • Genes, Dominant / genetics*
  • Humans
  • Male
  • Molecular Sequence Data
  • Mutation / genetics*
  • Oocytes / drug effects
  • Oocytes / metabolism
  • Pedigree
  • Protein Subunits
  • Receptors, Nicotinic / genetics*
  • Receptors, Nicotinic / metabolism
  • Scotland
  • Seizures / genetics
  • Seizures / physiopathology
  • Sleep Wake Disorders / genetics
  • Sleep Wake Disorders / physiopathology
  • Xenopus laevis

Substances

  • Protein Subunits
  • Receptors, Nicotinic
  • nicotinic receptor beta2
  • Acetylcholine